68Ga-Pentixafor PET/CT靶向CXCR4成像在大动脉炎中的应用
一例64岁女性大动脉炎患者接受CXCR4靶向全身68Ga-Pentixafor PET/CT评估疾病活动性并排除合并炎症性疾病。68Ga-Pentixafor PET显示主动脉壁CXCR4阳性炎症细胞浸润,活动性疾病经18F-FDG PET/CT进一步确认。68Ga-Pentixafor还发现一骨盆骨CXCR4阳性病灶,患者随后诊断为弥漫性大B细胞淋巴瘤。
要点
- 68Ga-Pentixafor PET可显示大动脉炎主动脉壁CXCR4阳性炎症细胞浸润。
- 68Ga-Pentixafor PET发现骨盆骨CXCR4阳性病灶,后续诊断为弥漫性大B细胞淋巴瘤。
- 作者认为CXCR4靶向68Ga-Pentixafor PET有助于检测大动脉炎活动性炎症及该恶性肿瘤风险增高人群中的肿瘤性疾病。
核心结论
- 作者认为CXCR4靶向68Ga-Pentixafor PET有助于检测大动脉炎的活动性炎症,并有助于在该恶性肿瘤风险增高的人群中检测肿瘤性疾病。
研究设计与样本
- 本文报告一例64岁女性大动脉炎病例,接受CXCR4靶向全身68Ga-Pentixafor PET/CT以进一步评估疾病活动性并排除合并炎症性疾病。
主要发现
- 68Ga-Pentixafor PET显示主动脉壁CXCR4阳性炎症细胞浸润。
- 活动性疾病经18F-FDG PET/CT进一步确认。
- 68Ga-Pentixafor识别出一处骨盆骨CXCR4阳性病灶,患者随后诊断为弥漫性大B细胞淋巴瘤。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We report a case of a 64-year-old woman with Takayasu arteritis who underwent chemokine receptor CXCR4-targeted whole-body 68 Ga-Pentixafor positron emission tomography/computed tomography (PET/CT) for further evaluation of disease activity and exclusion of concurrent inflammatory diseases. 68 Ga-Pentixafor PET demonstrated CXCR4-positive inflammatory cell infiltrates in the aortic wall, and active disease was further confirmed by 18 F-fluorodeoxyglucose (FDG) PET/CT. Moreover, 68 Ga-Pentixafor identified a CXCR4-positive pelvic bone lesion, and the patient was subsequently diagnosed with diffuse large B-cell lymphoma. CXCR4-targeted 68 Ga-Pentixafor PET is useful for the detection of active inflammation in Takayasu arteritis, and to detect neoplastic disease in this cohort with increased risk of malignancy.
引用
- Derlin T, Witte T. CXCR4-Targeted Imaging in Takayasu Arteritis Using 68 Ga-Pentixafor PET/CT. Clin Nucl Med. 2025. PMID: 40367500. doi:10.1097/RLU.0000000000005975
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。